During the past decade, Clinica Alemana de Osorno conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Alemana de Osorno" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Clinica Alemana de Osorno" are "Systemic Lupus Erythematosus" (2 trials). Many other conditions were trialed in "Clinica Alemana de Osorno" in a lesser frequency.

Most popular intervention types in "Clinica Alemana de Osorno" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Alemana de Osorno" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Clinica Alemana de Osorno". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Clinica Alemana de Osorno, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Alemana de Osorno, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".